Related Experiment Video

Updated: Jan 8, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

778

[Juvenile idiopathic arthritis-persistent oligoarticular subtype : Consensus-based treatment recommendations as part

Joachim Peitz1, Gerd Horneff1, Anna Raab2

  • 1Kinderrheumazentrum, Sankt Augustin, Zentrum für Allgemein Pädiatrie und Neonatologie, Asklepios Klinik Sankt Augustin, Sankt Augustin, Deutschland.

Zeitschrift Fur Rheumatologie
|December 12, 2025
PubMed

Insights

New clinical guidelines were established for oligoarticular juvenile idiopathic arthritis (JIA) through a consensus process. These protocols aim to optimize the classification, monitoring, and treatment of JIA in children and adolescents.

Area of Science:

  • Pediatric Rheumatology
  • Clinical Consensus Development

Background:

  • Juvenile idiopathic arthritis (JIA) requires standardized management protocols.
  • Oligoarticular JIA is a common subtype necessitating specific treatment strategies.

Purpose of the Study:

  • To develop consensus-based protocols for the classification, monitoring, and treatment of oligoarticular JIA.
  • To optimize care for both new-onset and persistent oligoarticular JIA.

Main Methods:

  • A consensus process involving the formulation of 23 statements.
  • An online survey distributed to members of the Society for Paediatric and Adolescent Rheumatology (GKJR).
  • A final online meeting to incorporate feedback and finalize statements.

Main Results:

  • 80 out of 124 pediatric rheumatologists participated (approx. 65% response rate).
  • 20 statements and a summary consensus treatment protocol were developed for oligoarticular JIA.
  • The protocols address classification, monitoring, and treatment optimization.

Conclusions:

  • Consensus-based protocols were successfully developed for oligoarticular JIA.
  • These guidelines provide a framework for optimizing JIA management.
  • The developed protocols aim to improve patient outcomes in pediatric rheumatology.

Keywords:
Intra-articular injectionsMethotrexateOff-label usePediatric rheumatologyTreat-to-target management

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

967
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

734

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
264
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
445
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
443
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
459
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
445
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
180